Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vaccination with melanoma lysate-pulsed dendritic cells, of patients with advanced colorectal carcinoma: report from a phase I study.
Burgdorf SK, Fischer A, Claesson MH, Kirkin AF, Dzhandzhugazyan KN, Rosenberg J. Burgdorf SK, et al. Among authors: dzhandzhugazyan kn. J Exp Clin Cancer Res. 2006 Jun;25(2):201-6. J Exp Clin Cancer Res. 2006. PMID: 16918131 Clinical Trial.
The immunogenic properties of human melanomas and melanoma-associated antigens recognized by cytotoxic T lymphocytes.
Zeuthen J, Dzhandzhugazyan K, Hansen MR, Kirkin AF. Zeuthen J, et al. Bratisl Lek Listy. 1998 Aug-Sep;99(8-9):426-34. Bratisl Lek Listy. 1998. PMID: 9810766 Review.
The immunogenic properties of melanoma-associated antigens recognized by cytotoxic T lymphocytes.
Kirkin AF, Dzhandzhugazyan K, Zeuthen J. Kirkin AF, et al. Exp Clin Immunogenet. 1998;15(1):19-32. doi: 10.1159/000019050. Exp Clin Immunogenet. 1998. PMID: 9619397 Review.
Melanoma-associated antigens recognized by cytotoxic T lymphocytes.
Kirkin AF, Dzhandzhugazyan K, Zeuthen J. Kirkin AF, et al. APMIS. 1998 Jul;106(7):665-79. doi: 10.1111/j.1699-0463.1998.tb00210.x. APMIS. 1998. PMID: 9740504 Review.
Establishment of gp100 and MART-1/Melan-A-specific cytotoxic T lymphocyte clones using in vitro immunization against preselected highly immunogenic melanoma cell clones.
Kirkin AF, thor Straten P, Hansen MR, Barfoed A, Dzhandzhugazyan KN, Zeuthen J. Kirkin AF, et al. Among authors: dzhandzhugazyan kn. Cancer Immunol Immunother. 1999 Aug;48(5):239-46. doi: 10.1007/s002620050571. Cancer Immunol Immunother. 1999. PMID: 10478640
Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells.
Kirkin AF, Dzhandzhugazyan KN, Guldberg P, Fang JJ, Andersen RS, Dahl C, Mortensen J, Lundby T, Wagner A, Law I, Broholm H, Madsen L, Lundell-Ek C, Gjerstorff MF, Ditzel HJ, Jensen MR, Fischer W. Kirkin AF, et al. Among authors: dzhandzhugazyan kn. Nat Commun. 2018 Mar 6;9(1):785. doi: 10.1038/s41467-018-03217-9. Nat Commun. 2018. PMID: 29511178 Free PMC article. Clinical Trial.
Cancer/testis antigens: structural and immunobiological properties.
Kirkin AF, Dzhandzhugazyan KN, Zeuthen J. Kirkin AF, et al. Among authors: dzhandzhugazyan kn. Cancer Invest. 2002;20(2):222-36. doi: 10.1081/cnv-120001150. Cancer Invest. 2002. PMID: 11901543 Review.
Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas.
Dzhandzhugazyan KN, Kirkin AF, thor Straten P, Zeuthen J. Dzhandzhugazyan KN, et al. FEBS Lett. 1998 Jul 3;430(3):227-30. doi: 10.1016/s0014-5793(98)00603-6. FEBS Lett. 1998. PMID: 9688544 Free article.
Diethyl pyrocarbonate inactivates CD39/ecto-ATPDase by modifying His-59.
Dzhandzhugazyan KN, Plesner L. Dzhandzhugazyan KN, et al. Biochim Biophys Acta. 2000 Jun 1;1466(1-2):267-77. doi: 10.1016/s0005-2736(00)00169-3. Biochim Biophys Acta. 2000. PMID: 10825448 Free article.
Adoptive T cell cancer therapy.
Dzhandzhugazyan KN, Guldberg P, Kirkin AF. Dzhandzhugazyan KN, et al. Nat Mater. 2018 Jun;17(6):475-477. doi: 10.1038/s41563-018-0094-5. Nat Mater. 2018. PMID: 29795224 No abstract available.
16 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback